The IFIGENEIA Project is pleased to announce the establishment of its External Expert Advisory Board (EAB), a distinguished group of internationally recognised experts who will provide strategic guidance and independent advice throughout the project’s implementation.
The Advisory Board brings together specialists from leading European research institutions, medical centres, and industry, covering key disciplines essential to the success of IFIGENEIA. Their collective expertise spans accelerator physics, nuclear medicine, medical radioisotopes, material science, biotechnology, innovation management, and regulatory frameworks.
The members of the External Advisory Board are:
- Angeles Faus-Golfe (IJCLab) – Accelerator Physics and Accelerator Technologies
- Antero Abrunhosa (ICNAS – Institute for Nuclear Sciences Applied to Health) – Biochemistry and Medical Applications of Radioisotopes
- Christos Sachpekidis (DKFZ – German Cancer Research Center) – Nuclear Medicine and Medical Applications of Radioisotopes
- Maria Kitsara (BIOEMTECH) – Material Science and Medical Radioisotope Applications
- Alexis Vrachimis (German Oncology Center, Cyprus) – Nuclear Medicine, Public Health, and Policy
- Thierry Stora (CERN – PRISMAP) – PRISMAP Coordinator / Innovation and Technology Transfer
- Dani Bach (Epicure Biotechnologies) – Business plan / Ethics and regulatory frameworks
After being identified by the Project Management Board and contacted by the Project Coordinator, all invited experts have enthusiastically confirmed their participation.
The External Advisory Board will play a critical role in ensuring the scientific excellence, technological relevance, and societal impact of the IFIGENEIA project. Through periodic consultations, the board will provide recommendations on research progress, innovation pathways, clinical translation, and regulatory considerations.
By bringing together leading voices from academia, healthcare, and industry, the Advisory Board strengthens IFIGENEIA’s mission to advance innovative solutions in radioisotope science and medical applications, ultimately contributing to improved healthcare technologies and patient outcomes.
The IFIGENEIA consortium warmly welcomes the Advisory Board members and looks forward to their valuable insights during the course of the project.